ZA901086B - Conjugates - Google Patents

Conjugates

Info

Publication number
ZA901086B
ZA901086B ZA901086A ZA901086A ZA901086B ZA 901086 B ZA901086 B ZA 901086B ZA 901086 A ZA901086 A ZA 901086A ZA 901086 A ZA901086 A ZA 901086A ZA 901086 B ZA901086 B ZA 901086B
Authority
ZA
South Africa
Prior art keywords
conjugates
Prior art date
Application number
ZA901086A
Other languages
English (en)
Inventor
David John Rowlands
John Rowlands David
Berwyn Ewart Clarke
Ewart Clarke Berwyn
Michael James Francis
James Francis Michael
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA901086B publication Critical patent/ZA901086B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA901086A 1989-02-14 1990-02-13 Conjugates ZA901086B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898903313A GB8903313D0 (en) 1989-02-14 1989-02-14 Conjugates

Publications (1)

Publication Number Publication Date
ZA901086B true ZA901086B (en) 1990-11-28

Family

ID=10651663

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901086A ZA901086B (en) 1989-02-14 1990-02-13 Conjugates

Country Status (11)

Country Link
EP (1) EP0385610B1 (de)
JP (1) JP2858848B2 (de)
AU (1) AU634518B2 (de)
CA (1) CA2009896A1 (de)
DE (1) DE69007311T2 (de)
DK (1) DK0385610T3 (de)
ES (1) ES2062330T3 (de)
GB (1) GB8903313D0 (de)
IE (1) IE64983B1 (de)
NZ (1) NZ232505A (de)
ZA (1) ZA901086B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207535T1 (de) * 1987-06-22 2001-11-15 Medeva Holdings Bv Hepatitis-b-oberflächenantigen enthaltendes peptid
EP0491077A1 (de) * 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
WO1992011291A1 (en) * 1990-12-20 1992-07-09 Smithkline Beecham Biologicals (S.A.) Vaccines based on hepatitis b surface antigen
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
FR2699538B1 (fr) * 1992-12-22 1995-02-03 Agronomique Inst Nat Rech Sous-unité d'une capsule protéique CS31A modifiée par au moins un peptide hétérologue, capsule protéique CS31A et microorganismes portant ces sous-unités; procédés d'obtention et utilisation de ceux-ci.
AU2540897A (en) * 1996-03-21 1997-10-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chimeric polypeptides for tumor antigen vaccines
ID26669A (id) * 1998-02-12 2001-01-25 Immune Complex Corp Inti protein-protein hepatitis b yang dimodifikasi secara strategi dan turunan-turunannya
AU770802B2 (en) 1998-10-21 2004-03-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Virus-like particles for the induction of autoantibodies
CN100534529C (zh) * 1998-11-30 2009-09-02 希托斯生物技术股份公司 抗原的有序分子呈递,制备及使用的方法
PL348766A1 (en) 1998-12-04 2002-06-03 Biogen Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
AU2001252458A1 (en) 2000-05-05 2001-11-20 Martin Bachmann Molecular antigen arrays and vaccines
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
MXPA05000277A (es) 2002-07-17 2005-03-31 Cytos Biotechnology Ag Configuraciones de antigenos moleculares de usan una particula tipo virus derivada de la proteina de recurimiento ap205.
KR101228376B1 (ko) 2002-07-18 2013-01-31 사이토스 바이오테크놀로지 아게 합텐-캐리어 컨쥬게이트 및 그의 용도
WO2004016282A1 (en) 2002-07-19 2004-02-26 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta1-6 antigen arrays
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
EP1605972A2 (de) 2003-03-26 2005-12-21 Cytos Biotechnology AG Hiv-peptid-träger-konjugate
US8080642B2 (en) 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
US20060024670A1 (en) 2004-05-18 2006-02-02 Luke Catherine J Influenza virus vaccine composition and methods of use
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
US10279028B2 (en) 2012-04-24 2019-05-07 Ohio State Innovation Foundation Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
CN104797269A (zh) 2012-04-24 2015-07-22 俄亥俄州国家创新基金会 用于治疗和预防猪繁殖与呼吸综合征的组合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
GB8709274D0 (en) * 1987-04-16 1987-05-20 Wellcome Found Peptides

Also Published As

Publication number Publication date
EP0385610B1 (de) 1994-03-16
ES2062330T3 (es) 1994-12-16
CA2009896A1 (en) 1990-08-14
AU4975590A (en) 1990-10-18
NZ232505A (en) 1992-12-23
DE69007311T2 (de) 1994-06-23
DE69007311D1 (de) 1994-04-21
IE64983B1 (en) 1995-09-20
GB8903313D0 (en) 1989-04-05
EP0385610A1 (de) 1990-09-05
JP2858848B2 (ja) 1999-02-17
JPH0327400A (ja) 1991-02-05
IE900502L (en) 1990-08-14
DK0385610T3 (da) 1994-07-25
AU634518B2 (en) 1993-02-25

Similar Documents

Publication Publication Date Title
GB8903313D0 (en) Conjugates
DE4090310D2 (en) Teleskopkrone
AU108277S (en) Hedge-shears
DE3991623D2 (en) Frequenzueberwachungsanordnung
EP0405242A3 (en) Vip-analogs ii
CS9005442A2 (en) Symmetrizer
CS490790A3 (en) Chaff-cutter
DE4090110D2 (en) Rotationskolbenverbrennungskraftmaschine
EP0504136A4 (en) Tolerogenic immunoglobulin-protein conjugates
GB8919661D0 (en) Superoxide dismutase-catalase conjugates
DE4091275D2 (en) Steppdecke
GB9003724D0 (en) Toychest ii
BG49771A1 (en) Electric- bow evaparator
EP0430866A3 (en) Connection piece
DE4090763D2 (en) Abfallsammler
DE4091102D2 (de) Spundlochverschluss
DE4090235D2 (de) Hauptabsperrventil
DE3991687D2 (de) Dufttresor
DE3991686D2 (de) Schmuckblende
NZ238953A (en) Antibody-superantigen conjugates
IE883489L (en) Drug-monoclonalantibody conjugates
CA64463S (en) Tapeplayer
CA64817S (en) Liminaire
CA64838S (en) Automibile
DE3991146D2 (en) Schraubverschluss